Maven Clinic and Color Health Partner to Integrate Fertility Preservation into Cancer Care
Event summary
- Maven Clinic and Color Health announced a partnership on February 12, 2026, to expand access to oncofertility care for cancer patients of childbearing age.
- The program integrates Color's oncologist-led care with Maven's fertility preservation services, initially available through employers and health plans.
- Cancer treatments can significantly impact fertility, yet fewer than 50% of patients report discussing fertility preservation options with their oncologists.
- The partnership aims to improve access, equity, and outcomes in oncofertility care by providing early referrals, evidence-based counseling, and expedited access to fertility clinics.
The big picture
The partnership addresses a critical gap in cancer care, where fertility preservation is often overlooked despite its importance for long-term quality of life. With rising cancer rates among young adults and the high cost of cancer and women's health care, integrated solutions like this are increasingly in demand. Maven and Color aim to transform how patients are supported from diagnosis through survivorship, potentially setting a new standard in oncofertility care.
What we're watching
- Market Adoption
- How quickly employers and health plans will integrate the oncofertility services into their benefits programs.
- Clinical Outcomes
- Whether the partnership can demonstrate improved fertility preservation outcomes for cancer patients.
- Scalability
- The pace at which Maven and Color can expand the program to reach a broader patient population.
Related topics